Intrust Bank’s DexCom DXCM Stock Holding History

Intrust Bank’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,875	Closed	-$261K	–	399
2025 Q3	$261K	Sell	3,875 -1,059	-21%	-$83.8K	0.02%	353
2025 Q2	$431K	Buy	4,934 +976	+25%	+$76.5K	0.04%	280
2025 Q1	$270K	Buy	+3,958	New	+$323K	0.03%	336

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Intrust Bank's DXCM Position: Q4 2025 in Review

Intrust Bank sold out of DexCom (DXCM) in Q4 2025, closing a stake of 3,875 shares — an estimated $261K sold.

Intrust Bank first reported a position in DXCM in Q1 2025 and held it in 3 quarters. The position peaked at $431K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Intrust Bank reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Intrust Bank sold 3,875 DexCom shares in Q4 2025, an estimated $261K.
Intrust Bank first reported a position in DexCom in Q1 2025 and held it in 3 quarters.
Intrust Bank's DexCom position peaked at $431K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Intrust Bank's 13F filing for Q4 2025, filed 6 Feb 2026.